Beam Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Beam Therapeutics Inc
TickerBEAM
CIK #0001745999
CUSIP07373V105
SectorLife Sciences - Biological Products, (No Disgnostic Substances)
Address26 Landsdowne Street, Cambridge, MA 02139
Source [EDGAR]
CIK Filing 2011 - 2024
[0001745999] 10-K
[0001745999] 10-Q
[0001745999] 3
[0001745999] 4
[0001745999] 8-K
[0001745999] D
[0001745999] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Temasek Holdings Private Ltd Beam Therapeutics Inc [2023-03-17] 5.0
Farallon Capital Partners LP Beam Therapeutics Inc [2022-07-14] 0.4
Vanguard Group Inc Beam Therapeutics Inc [2022-02-09] 6.89
BlackRock Inc Beam Therapeutics Inc [2022-02-04] 6.0
ARK Investment Management LLC Beam Therapeutics Inc [2021-06-10] 10.08
Hillhouse Capital Advisors Ltd Beam Therapeutics Inc [2021-02-16] 5.1
Redmile Group LLC Beam Therapeutics Inc [2021-02-16] 6.5
Temasek Holdings Private Ltd Beam Therapeutics Inc [2021-02-05] 5.7
Arch Venture Fund IX LP Beam Therapeutics Inc [2021-02-02] 13.5
BlackRock Inc Beam Therapeutics Inc [2021-02-02] 5.5
FMR LLC Beam Therapeutics Inc [2020-02-12] 0.0
Form 3/4/5 Filer 2011 - 2024
Maraganore John
Beam Therapeutics Inc.
Walsh Kathleen E
Fishman Mark
Ho Carole
Burow Kristina
Cooper Graham K
Ciaramella Giuseppe
Bellon Christine
Burrell Terry-Ann
Simon Amy
Evans John M.
FMR LLC
ARCH Venture Partners IX, L.P.
Crandell Keith
ARCH Venture Partners IX Overage, L.P.
ARCH Venture Fund IX Overage, L.P.
Nelsen Robert
ARCH Venture Partners IX, LLC
Bybee Clinton
ARCH Venture Fund IX, L.P.
Verve Therapeutics, Inc.
Green Jeremy
Redmile Group, LLC
Knight Stephen C
Form 13F Holdings
Firm Period DFND Voting Shares
ARK Investment Management LLC [2023-03-31] SOLE 8,390,948.0 8,573,429.0
Vanguard Group Inc [2023-03-31] SOLE 0.0 6,217,361.0
FMR LLC [2023-03-31] DFND 6,086,604.0 6,087,553.0
BlackRock Inc. [2023-03-31] SOLE 5,166,741.0 5,290,311.0
Temasek Holdings (Private) Ltd [2023-03-31] DFND 4,094,512.0 4,094,512.0
Farallon Capital Management LLC [2023-03-31] OTR 3,431,921.0 3,431,921.0
State Street Corp [2023-03-31] DFND 3,099,671.0 3,236,088.0
MWG Management Ltd. [2023-03-31] DFND 2,346,934.0 2,346,934.0
Redmile Group LLC [2023-03-31] SOLE 1,612,094.0 1,612,094.0
Deep Track Capital LP [2023-03-31] SOLE 1,250,000.0 1,250,000.0
Geode Capital Management LLC [2023-03-31] DFND 1,202,329.0 1,202,329.0
SC CHINA HOLDING Ltd [2023-03-31] DFND 796,089.0 796,089.0
Morgan Stanley [2023-03-31] DFND 666,625.0 730,128.0
JPMorgan Chase & Co [2023-03-31] DFND 576,854.0 718,802.0
Bellevue Group AG [2023-03-31] DFND 695,421.0 695,421.0
Sumitomo Mitsui Trust Holdings, Inc. [2023-03-31] DFND 658,566.0 658,566.0
Nikko Asset Management Americas Inc [2023-03-31] SOLE 370,244.0 658,566.0
Goldman Sachs Group Inc [2023-03-31] DFND 657,516.0 658,258.0
Northern Trust Corp [2023-03-31] DFND 37,919.0 607,088.0
Casdin Capital LLC [2023-03-31] SOLE 570,000.0 570,000.0
Susquehanna International Group LLP [2023-03-31] DFND 181,357.0 521,357.0
Capital Research Global Investors [2023-03-31] DFND 491,882.0 491,882.0
Bank of New York Mellon Corp [2023-03-31] DFND 434,043.0 468,177.0
Yiheng Capital Management LP [2023-03-31] SOLE 463,800.0 463,800.0
Charles Schwab Investment Management Inc [2023-03-31] SOLE 463,614.0 463,614.0
Eventide Asset Management LLC [2023-03-31] SOLE 459,203.0 459,203.0
Pictet Asset Management Sa [2023-03-31] DFND 1.0 387,235.0
Citadel Advisors LLC [2023-03-31] DFND 385,300.0 385,300.0
Bank of America Corp /DE/ [2023-03-31] DFND 9,465.0 377,620.0
Baillie Gifford & Co [2023-03-31] DFND 219,797.0 325,956.0
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com